Login

Gianmarco Lanza, CEO of FAE Technology SB S.p.A., will be the guest speaker at the upcoming free Smart Webinar. 00:10:00

Share On Facebook Share On Twitter

Videointervista Gianmarco Lanza – CEO FAE Technology

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Biotech Analysts Unveil AI's Impact: Revolutionizing Drug Discovery for a Promising 2024|JEFFREY M. SOLOMON,President, TD Cowen
00:10:00
Componenta as an Investment - Investor Day 28.11.2022| Sami Sivuranta , CEO of Componenta
00:10:00
Arizona Copper Project Poised for Production in 2025
00:10:00
At the 25 Years MCI event, Christoph Vilanek of freenet AG and Thierry Bernard, CEO of QIAGEN N.V., engage in a distinguished guest live talk.
00:10:00
Fuller Industrial: Comprehensive Solutions for Cost-Efficient Global Operations
00:10:00
Weathering Economic Storms: Strategies for Portfolio Protection | Donald C Wood, CEO, Federal Realty Investment Trust.
00:00:00
Shield Therapeutics "ended 2022 in a very very productive state" - Greg Madison Chief Executive Officer, Shield Therapeutics P
00:10:00
Capricorn Metals: Advancing Towards Gold Production in 2019 at One-to-One Mining Conference in London
00:10:00
African Gold Group: Kabada Project Advancements and Exploration Upside in Southern Mali
00:10:00
"David G. Booth on Business, Policy, and Economic Growth at Illinois Policy Institute Event"
00:10:00
Ireland's EU Journey and Identity Challenges|Mark Dooley,Professor,Boston College
00:10:00
This is how a successful IT career began in Salzburg | Peter Belly, Managing Director, B+S Banksysteme AGDTD2X:GER

© 2017 - Neuhu+